304 related articles for article (PubMed ID: 25706362)
1. Ultrasound findings in fetal congenital heart block associated with maternal anti-Ro/SSA and Anti-La/SSB antibodies.
Lai J; Clark TJ; Tan JH; Delaney S; Jolley JA
Ultrasound Q; 2015 Mar; 31(1):34-6. PubMed ID: 25706362
[TBL] [Abstract][Full Text] [Related]
2. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
Ayed K; Gorgi Y; Sfar I; Khrouf M
Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
[TBL] [Abstract][Full Text] [Related]
3. Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone.
Theander E; Brucato A; Gudmundsson S; Salomonsson S; Wahren-Herlenius M; Manthorpe R
J Rheumatol; 2001 Feb; 28(2):373-6. PubMed ID: 11246681
[TBL] [Abstract][Full Text] [Related]
4. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
[TBL] [Abstract][Full Text] [Related]
5. Complete heart block in a fetus associated with maternal Sjögren's syndrome.
Veille JC; Sunderland C; Bennett RM
Am J Obstet Gynecol; 1985 Mar; 151(5):660-1. PubMed ID: 3872074
[TBL] [Abstract][Full Text] [Related]
6. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
[TBL] [Abstract][Full Text] [Related]
7. Recurrent congenital heart block in neonatal lupus.
Escobar MC; Gómez-Puerta JA; Albert D; Ferrer Q; Girona J
Clin Rheumatol; 2007 Jul; 26(7):1161-3. PubMed ID: 16586043
[TBL] [Abstract][Full Text] [Related]
8. Prevention of recurrent congenital heart block in a SSA/SSB positive mother using high dose maternal IVIG from 16-week gestation.
Sterling RA; Carlin A
Prenat Diagn; 2015 Nov; 35(11):1148-50. PubMed ID: 26179183
[No Abstract] [Full Text] [Related]
9. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.
Sonesson SE; Salomonsson S; Jacobsson LA; Bremme K; Wahren-Herlenius M
Arthritis Rheum; 2004 Apr; 50(4):1253-61. PubMed ID: 15077309
[TBL] [Abstract][Full Text] [Related]
10. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
Chang YL; Hsieh PC; Chang SD; Chao AS; Liang CC; Soong YK
Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):167-71. PubMed ID: 16219517
[TBL] [Abstract][Full Text] [Related]
11. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.
Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M
Lupus; 2006; 15(6):346-53. PubMed ID: 16830880
[TBL] [Abstract][Full Text] [Related]
12. Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies.
Gladman G; Silverman ED; Yuk-Law ; Luy L; Boutin C; Laskin C; Smallhorn JF
Am J Perinatol; 2002 Feb; 19(2):73-80. PubMed ID: 11938480
[TBL] [Abstract][Full Text] [Related]
13. Congenital fetal heart block: a potential therapeutic role for intravenous immunoglobulin.
David AL; Ataullah I; Yates R; Sullivan I; Charles P; Williams D
Obstet Gynecol; 2010 Aug; 116 Suppl 2():543-547. PubMed ID: 20664449
[TBL] [Abstract][Full Text] [Related]
14. Prospective echocardiographic evaluation of atrioventricular conduction in fetuses with maternal Sjögren's antibodies.
Van Bergen AH; Cuneo BF; Davis N
Am J Obstet Gynecol; 2004 Sep; 191(3):1014-8. PubMed ID: 15467582
[TBL] [Abstract][Full Text] [Related]
15. Anti-Ro (SSA) and anti-La (SSB) antibodies and complete congenital heart block.
Finkelstein Y; Adler Y; Harel L; Nussinovitch M; Youinou P
Ann Med Interne (Paris); 1997; 148(3):205-8. PubMed ID: 9255327
[TBL] [Abstract][Full Text] [Related]
16. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
Meyer O
Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
[TBL] [Abstract][Full Text] [Related]
17. More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block.
Clancy RM; Buyon JP
Rheum Dis Clin North Am; 2004 Aug; 30(3):589-602, x. PubMed ID: 15261343
[TBL] [Abstract][Full Text] [Related]
18. [Intrauterine treatment of incomplete fetal heart block in a mother with Sjögren syndrome].
Hagen A; Albig M; Schmitz L; Hopp H; Entezami M
Ultraschall Med; 2008 Dec; 29 Suppl 5():268-70. PubMed ID: 18008217
[TBL] [Abstract][Full Text] [Related]
19. Complete congenital heart block followed by anti-Ro/SSA in adult life. Studies of an informative family.
Reichlin M; Friday K; Harley JB
Am J Med; 1988 Feb; 84(2):339-44. PubMed ID: 3261539
[TBL] [Abstract][Full Text] [Related]
20. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
